Search - tctmd.com

Displaying 61 - 80 of 700

Sort: Relevancy | Date

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

Yael L. Maxwell

August 20, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

Presentation TVT 2019

Successful BASILICA for a Failed CoreValve

Presenter: Ikki Komatsu

June 15, 2019

Presentation TVT 2019

Highlights From the CoreValve Low-Risk Trial

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Successful BASILICA for a Failed CoreValve

Presenter: Ikki Komatsu

June 13, 2019

Presentation TVT 2019

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Transcatheter Aortic Valve Replacement Using the CoreValve Prosthesis for the Treatment of Severe Aortic Regurgitation: A Single-Center Learning Curve Over 6 Years

Presenter: Giselle Baquero

June 13, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

Advertisement

ACS After TAVR a Unique Condition With Poor Prognosis

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Portico Noninferior to Commercial TAVR Valves in IDE Study

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

FDA Expands TAVR Indication to Low-Risk Patients

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Successful BASILICA for a Failed CoreValve

Highlights From the CoreValve Low-Risk Trial

Successful BASILICA for a Failed CoreValve

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Transcatheter Aortic Valve Replacement Using the CoreValve Prosthesis for the Treatment of Severe Aortic Regurgitation: A Single-Center Learning Curve Over 6 Years

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content